Ramtin Agah, M.D.

Chairman

Equibles does not estimate personal net worth.

Get an email with a short summary when RenovoRx, Inc. publishes a filing, an earnings call transcript or a press release.

Get RNXT alerts

About Ramtin Agah, M.D.

Ramtin Agah, M.D. is recorded as Chairman at RenovoRx, Inc. (RNXT) since February 27, 2026. RenovoRx, Inc. reported in an 8-K filed March 27, 2026 that Ramtin Agah, M.D. was appointed Executive Chairman, effective February 27, 2026. Ramtin Agah, M.D. has spoken on 1 earnings call across 1 company, most recently for RenovoRx, Inc. on March 30, 2026. RenovoRx, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at RenovoRx, Inc. includes Shaun Bagai (CEO and Board Member), Shaun R. Bagai (CEO and Board Member), Ramtin Agah (Chairman) and 7 others.

“On March 24, 2026, the board of directors (the “Board”) of RenovoRx, Inc., a Delaware corporation (the “Company”), formally appointed Ramtin Agah, M.D., Chief Medical Officer and Chairman of the Board of the Company, to the newly created position of Executive Chairman, effective February 27, 2026.”

RenovoRx, Inc. Form 8-K, filed March 27, 2026 · Read the filing

Ramtin Agah, M.D. on recent calls

“I want to begin by saying that I'm genuinely excited about where this company stands today, not despite our challenges, but in full view of them. Building a company is hard.”

Chairman, RenovoRx, Inc. Q4 FY2025 Earnings Call · March 30, 2026